DK0765664T3 - Stabil vandig suspension af mesalazin til topisk anvendelse - Google Patents

Stabil vandig suspension af mesalazin til topisk anvendelse

Info

Publication number
DK0765664T3
DK0765664T3 DK96110263T DK96110263T DK0765664T3 DK 0765664 T3 DK0765664 T3 DK 0765664T3 DK 96110263 T DK96110263 T DK 96110263T DK 96110263 T DK96110263 T DK 96110263T DK 0765664 T3 DK0765664 T3 DK 0765664T3
Authority
DK
Denmark
Prior art keywords
mesalazine
aqueous suspension
topical use
stable aqueous
stable
Prior art date
Application number
DK96110263T
Other languages
Danish (da)
English (en)
Inventor
Giancarlo Farolfi
Franco Lattuada
Laura Ferro
Original Assignee
Crinos Industria Farmaco
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Crinos Industria Farmaco filed Critical Crinos Industria Farmaco
Application granted granted Critical
Publication of DK0765664T3 publication Critical patent/DK0765664T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Colloid Chemistry (AREA)
  • Lubricants (AREA)
  • Color Printing (AREA)
  • Electrically Operated Instructional Devices (AREA)
DK96110263T 1995-09-28 1996-06-26 Stabil vandig suspension af mesalazin til topisk anvendelse DK0765664T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95MI001987A IT1277663B1 (it) 1995-09-28 1995-09-28 Sospensioni acquose stabili di mesalazina per uso topico

Publications (1)

Publication Number Publication Date
DK0765664T3 true DK0765664T3 (da) 2002-05-21

Family

ID=11372286

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96110263T DK0765664T3 (da) 1995-09-28 1996-06-26 Stabil vandig suspension af mesalazin til topisk anvendelse

Country Status (9)

Country Link
US (1) US5731302A (it)
EP (1) EP0765664B1 (it)
JP (1) JP4251671B2 (it)
AT (1) ATE215374T1 (it)
DE (1) DE69620327T2 (it)
DK (1) DK0765664T3 (it)
ES (1) ES2172611T3 (it)
IT (1) IT1277663B1 (it)
PT (1) PT765664E (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6326364B1 (en) 1999-02-08 2001-12-04 Cedars-Sinai Medical Center Use of 5-aminosalicylates as antimicrobial agents
GB9930058D0 (en) * 1999-12-20 2000-02-09 Novartis Ag Organic compounds
DK1313697T3 (da) * 2000-08-29 2006-04-10 Nobex Corp Immunregulatoriske forbindelser, derivater deraf samt anvendelse deraf
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
PT1997478E (pt) * 2001-02-15 2013-12-10 Access Pharma Inc Formulações líquidas para a prevenção e para o tratamento de doenças e distúrbios das mucosas
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
CA2520197A1 (en) * 2003-04-23 2004-11-04 Ferring B.V. Sachet for a pharmaceutical composition
DK1773767T3 (en) 2004-07-07 2016-03-21 Biocon Ltd Synthesis of azo bound in immune regulatory relations
US7645801B2 (en) 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
KR20080076667A (ko) * 2007-02-15 2008-08-20 주식회사 중외제약 요변성 약학 조성물
CA2746768A1 (en) * 2008-12-17 2010-07-08 Altheus Therapeutics, Inc. Enema formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664256A (en) * 1983-09-06 1987-05-12 Farmaceutisk Laboratorium Ferring A/S Packaged stable enema solution or suspension containing 5-aminosalicyclic acid
US4657900A (en) * 1983-09-27 1987-04-14 Rowell Laboratories Pharmaceutical article of manufacture comprising a bisulfite stabilized aqueous solution of 5-aminosalicylic acid and method
US5010069A (en) * 1989-05-15 1991-04-23 Marion Laboratories, Inc. Stable liquid form of 5-aminosalicylic acid
US5378470A (en) * 1989-07-25 1995-01-03 Henning Berlin Gmbh Rectally administered pharmaceutical preparation
DE3924570A1 (de) * 1989-07-25 1991-01-31 Henning Berlin Gmbh Pharmazeutische zubereitung zur rektalen verabreichung
IT1243379B (it) * 1990-07-27 1994-06-10 Giuliani Spa Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico
GB9101621D0 (en) * 1991-01-25 1991-03-06 Bioglan Lab Ltd A packaged pharmaceutical product

Also Published As

Publication number Publication date
EP0765664A1 (en) 1997-04-02
US5731302A (en) 1998-03-24
ITMI951987A1 (it) 1997-03-28
ATE215374T1 (de) 2002-04-15
DE69620327T2 (de) 2002-11-21
ITMI951987A0 (it) 1995-09-28
ES2172611T3 (es) 2002-10-01
DE69620327D1 (de) 2002-05-08
PT765664E (pt) 2002-07-31
IT1277663B1 (it) 1997-11-11
JP4251671B2 (ja) 2009-04-08
JPH09110697A (ja) 1997-04-28
EP0765664B1 (en) 2002-04-03

Similar Documents

Publication Publication Date Title
EP0877793A4 (en) CLONE VEGETABLE DIOXYGENASE OF P-HYDROXYPHENYLPYRUVIC ACID
FI955420A7 (fi) BMP-10 koostumukset
DE69516678D1 (de) Laser-markieren von fluorpolymer-zusammensetzungen
FI955419L (fi) BMP-11 koostumukset
DE69628375D1 (de) Kürzestzeit Alternativzielplaner
DK0765664T3 (da) Stabil vandig suspension af mesalazin til topisk anvendelse
MX9202855A (es) Formulaciones en aerosol de suspension de sulfato de albuterol.
DE69433493D1 (de) Stabilisierte kationisch härtbare Zusammensetzungen
FI990596A0 (fi) Luun morfogeneettiset proteiini-16 (BMP-16) -koostumukset
KR970702719A (ko) 사이클로덱스트린을 함유한 점막점착성 유제(Mucoadhesive emulsions containing cyclodextrin)
DZ1835A1 (fr) Nouvelles formulations.
TR28150A (tr) Stabilize edilmis agartma bilesimleri.
DE69202164D1 (de) Stabilisierung von Thiolenzusammensetzungen.
FI980387A0 (fi) Foerfarande foer att foerhindra bildning av utfaellningar i svartlutsindunstare
EP0570884A3 (en) Positive working resist composition.
MA26543A1 (fr) Derives de pyrrolopyrrolone comme inhibiteurs d'elastase de neutrophiles.
FI954188L (fi) Vesiperustaiset maaliainekoostumukset
DE69404238D1 (de) Papierbeschichtungsmittel
EP0641189A4 (en) COSMETIC COMPOSITIONS.
NL194844B (nl) Catadioptrisch reductie-objectief.
FR2741535B1 (fr) Nouvelles preparations pour la sphere bucco-pharyngee
DE69736371D1 (de) Bieten um Bandbreite
ITRM940378A0 (it) Composizioni erbicide.
DE69435089D1 (de) UV-stabile Zusammensetzungen
DE69622377D1 (de) Wasserbasierte korrekturflüssigkeit